What’s new with DNA and RNA?
Eukaryotic gene expression is regulated at multiple layers. This session will cover emerging new mechanisms of gene expression regulation, centered around DNA and RNA. We will hear updates on regulation at the nucleosome structure and chromatin conformation level, how noncoding RNAs could impact transcription, and RNA modifications in post-transcriptional gene expression regulation. This session also will introduce diverse modern imaging technologies to visualize transcription activity and spatial transcriptome.
Keywords: chromatin structure, noncoding RNA, RNA modifications, super-resolution imaging, spatial transcriptome
Who should attend: students, postdocs and anyone interested in gene expression regulation, nucleosome structure and chromatin conformation, noncoding RNA and RNA modifications, super-resolution imaging and spatial transcriptome
Theme song: "The DNA Song" by Jam Campus (parody of "Trap Queen" by Fetty Wap)
This session is powered by nucleic acids.
Talks
- Cracking the nucleus: Finding order in chaos — Clodagh O'Shea, Salk Institute
- EM structures of nucleosomes with chaperones — Karolin Luger, University of Colorado Boulder
- Structural mechanism of human telomerase holoenzyme — Kelly Nguyen, Medical Research Council Laboratory of Molecular Biology
- Studying DNA-related processes on DNA curtains — Ilya Finkelstein, University of Texas at Austin
- m6A in the action of regulating the regulators — Kathy (Fange) Liu, University of Pennsylvania
- Jeannie Lee, Massachusetts General Hospital
- RNA methylation multitasking on chromatin — Blerta Xhemalce, University of Texas at Austin
- RNA methylation in gene expression regulation — Chuan He, University of Pennsylvania
- Visualizing RNA in life cells — Timothy Stasevich, Colorado State University
- Visualizing the dynamic genome during development, Alistair Boettiger, Stanford University
- 3D in situ RNA sequencing — Xiao Wang, Broad Institute and Massachusetts Institute of Technology
- Engineering the repetitive 3D genome in human disease— Jennifer Phillips–Cremins, University of Pennsylvania
Learn more
Check out all ten thematic symposia planned for the 2022 ASBMB annual meeting:
- Diversity, equity and inclusion
- Protein machines and disorder
- Signaling
- Quality control in organelles
- Metabolism
- Enzymology
- RNA/DNA
- Membranes/lipids
- Glycobiology
- Education and professional development
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreFeatured jobs
from the ASBMB career center
Get the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Gaze into the proteomics crystal ball
The 15th International Symposium on Proteomics in the Life Sciences symposium will be held August 17–21 in Cambridge, Massachusetts.
Bacterial enzyme catalyzes body odor compound formation
Researchers identify a skin-resident Staphylococcus hominis dipeptidase involved in creating sulfur-containing secretions. Read more about this recent Journal of Biological Chemistry paper.
Neurobiology of stress and substance use
MOSAIC scholar and proud Latino, Bryan Cruz of Scripps Research Institute studies the neurochemical origins of PTSD-related alcohol use using a multidisciplinary approach.
Pesticide disrupts neuronal potentiation
New research reveals how deltamethrin may disrupt brain development by altering the protein cargo of brain-derived extracellular vesicles. Read more about this recent Molecular & Cellular Proteomics article.
A look into the rice glycoproteome
Researchers mapped posttranslational modifications in Oryza sativa, revealing hundreds of alterations tied to key plant processes. Read more about this recent Molecular & Cellular Proteomics paper.
Proteomic variation in heart tissues
By tracking protein changes in stem cell–derived heart cells, researchers from Cedars-Sinai uncovered surprising diversity — including a potential new cell type — that could reshape how we study and treat heart disease.